News

A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...
AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...
A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...
A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.
A MUM was terrified her boob job would kill her after it led to a rare disease. Colette Cooper went under the knife in 2014 ...
Pfizer and Allergan said the effective tax rate of the new company would be 17% to 18%, well below Pfizer’s effective tax rate last year of 25.5%.
Lab workers examine samples at an Allergan research site in France. A U.S. judge has cast doubt on the company’s scheme to protect its drug patents by trading them to a New York Indian tribe.
U.S. pharmaceutical giant Pfizer (PFE) and Irish rival Allergan (AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet ...
Actavis is nearing a deal to acquire Allergan in a tie-up that would likely be the year’s largest and could help shield the Botox maker from hostile suitor Valeant.